Fennec Pharmaceuticals Inc. (FENC) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 7 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for FENC is $18.00, representing a +188.0% upside from the current price of $6.25. Price targets range from a low of $18.00 to a high of $18.00.
